An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Discover how Bruker is advancing live single-cell functional analysis, helping to accelerate breakthroughs in immunology and ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Promising early results from the first human clinical trials with new HIV germline-targeting vaccines were reported. These ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.

Allogene Therapeutics is cutting back to stretch its cash runway into the second half of 2027, laying off 28% of its ...

Presenting new clinical data from Phase 1/2 multi-center clinical trial of LYL314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate for the treatment of relapsed and/or refracto ...

Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

Researchers create a magnetic nanoscale system that reversibly switches groove and ridge structures to regulate stem cell ...

A. Quantitative value of hepatic ERK activation in lean mice, obese mice without suppression of colonic inflammation and ...